L3VLUP
ProSign in

UHS · ELV in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

UHSELV
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • UHS
  • ELV
010203040202120222023202420252026
Holders and value by quarter
QuarterUHSELV
Q3 202013 holders, $1.8bn30 holders, $15.0bn
Q4 202017 holders, $2.5bn29 holders, $16.7bn
Q1 202116 holders, $2.4bn25 holders, $18.6bn
Q2 202115 holders, $2.6bn30 holders, $19.4bn
Q3 202114 holders, $2.5bn26 holders, $18.5bn
Q4 202114 holders, $2.4bn29 holders, $23.3bn
Q1 202213 holders, $2.6bn31 holders, $23.9bn
Q2 202214 holders, $1.9bn32 holders, $23.3bn
Q3 202214 holders, $1.6bn34 holders, $22.6bn
Q4 202215 holders, $3.1bn34 holders, $25.5bn
Q1 202316 holders, $2.5bn39 holders, $22.5bn
Q2 202320 holders, $3.0bn38 holders, $20.6bn
Q3 202317 holders, $2.4bn34 holders, $19.8bn
Q4 202317 holders, $3.2bn36 holders, $20.3bn
Q1 202416 holders, $3.5bn35 holders, $21.3bn
Q2 202415 holders, $3.0bn33 holders, $22.1bn
Q3 202419 holders, $3.5bn30 holders, $20.2bn
Q4 202417 holders, $2.1bn32 holders, $15.9bn
Q1 202518 holders, $2.1bn28 holders, $17.1bn
Q2 202515 holders, $1.9bn27 holders, $14.8bn
Q3 202513 holders, $2.0bn27 holders, $12.7bn
Q4 202511 holders, $1.8bn25 holders, $17.0bn
Q1 202612 holders, $1.5bn26 holders, $13.6bn
Q2 20267 holders, $1.1bn28 holders, $17.7bn
UHS

Universal HLTH SVCS Inc

Holders
17
Reported value
$2.1bn
Buyers
9
Sellers
8

Breadth +1 among 94 comparable managers.

Health care services and research
ELV

Elevance Health Inc Formerly

Holders
32
Reported value
$15.9bn
Buyers
20
Sellers
12

Breadth +8 among 94 comparable managers.

Health care services and researchManaged care

Who holds both, Q4 2024

Among the 38 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only UHS (6)

Balyasny Asset Management LLC, Caxton Associates LLP, Citadel Advisors LLC, Freestone Grove Partners LP, Glenview Capital Management LLC, Woodline Partners LP

Only ELV (21)

AllianceBernstein LP, Artisan Partners LP, Baillie Gifford & Co, Brevan Howard Capital Management LP, D. E. Shaw & Co., D1 Capital Partners LP, Dodge & Cox, ExodusPoint Capital Management LP, Fidelity (FMR LLC), Harris Associates LP, Invesco Ltd, Janus Henderson Group Ltd, Neuberger Berman Group LLC, Renaissance Technologies LLC, Ruane Cunniff & Goldfarb LP, T. Rowe Price Associates Inc, Tudor Investment Corp, Two Sigma Advisers LP, Two Sigma Investments LP, Voloridge Investment Management LLC, Wellington Management Group LLP

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →